ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Vetr Announces Plans to Offer ToltraMax Oral Solution Upon Platform Launch

GRANTS PASS, OR, May 16, 2025 (EZ Newswire) -- Vetr, an upcoming telehealth platform focused on providing pet owners with access to veterinary products and services, has announced its intention to include ToltraMax, a toltrazuril-based oral solution, as part of its product offerings when the platform launches later this year.

ToltraMax is an oral solution formulated for use in multiple species, including dogs, cats, horses and other non food chain animals. Its active ingredient, toltrazuril, is widely used in veterinary settings to manage intestinal health challenges related to coccidia, a common protozoan parasite affecting a variety of animals.

While Vetr’s platform is still in development, ToltraMax is currently available for purchase through Amazon, Walmart, horseprerace.com, toltrazuril.com, and vetr.com, serving caretakers of equine and companion animals.

“Expanding access to essential veterinary products is a core part of Vetr’s mission,” said Andrew Hamilton, founder and CEO of Vetr. “ToltraMax aligns with our goal of providing practical, broad-use solutions and compounded drugs for pet owners and animal caretakers, making it an important addition to our future product lineup.”

Vetr aims to simplify the process of obtaining veterinary-recommended medications through a digital platform designed for convenience and accessibility. The platform will offer an online pharmacy, educational resources, and telehealth consultations, supporting responsible pet care and providing guidance on product usage.

Recently, Vetr secured $21 million in funding from Palehorse Capital to support the platform’s development and product expansion, including a nationwide online pharmacy. This investment will assist in launching a comprehensive online marketplace for veterinary products, including ToltraMax, alongside efforts to lower the overall cost of pet medications for consumers.

Upon launch, Vetr will provide pet owners with a streamlined purchasing experience, while emphasizing the importance of professional veterinary consultation. The platform will not replace veterinary care but will serve as an additional resource for accessing trusted products and information.

For updates on Vetr’s launch and product availability, visit vetr.com.

About Vetr

Vetr is a telehealth platform transforming pet healthcare by making veterinary services more affordable, accessible and efficient. Through its easy-to-use app, pet owners can schedule appointments, consult remotely with licensed veterinarians and access low-cost, over-the-counter animal prescriptions. Founded by Andrew Hamilton, Vetr is dedicated to delivering high-quality, cost-effective care for pets nationwide. With a focus on generic medications and virtual care, Vetr is redefining how modern pet owners manage their animals’ health. Learn more at vetr.com.

Media Contact

Media Relations
sales@vetr.com
###

SOURCE: Vetr

Copyright 2025 EZ Newswire

See release on EZ Newswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.